Stan G. Louie
- Physiology top 1%
- Adenosine and Purinergic Signaling 8
- Virology top 2%
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 10
- Hepatology top 5%
- Oncology top 5%
- PARP inhibition in cancer therapy 8
-
- Cystic Fibrosis Research Advances 10
-
- Endoplasmic Reticulum Stress and Disease 10
-
- Eicosanoids and Hypertension Pharmacology 9
-
- Antibiotics Pharmacokinetics and Efficacy 9
-
- Autophagy in Disease and Therapy 8
- Co-authors
- Axel H. SchönthalThomas C. ChenFlorence M. HofmanNicos A. PetasisEncouse B. GoldenHee‐Yeon ChoNatalie BzowejAmy Rock Wohl
- Partner nations
- United StatesNorwayCanada
In The Last Decade
Stan G. Louie
147 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 156
- Physiology 267
- Virology 260
- Infectious Diseases 773
- Hepatology 289
- Oncology 956
Countries citing papers authored by Stan G. Louie
This map shows the geographic impact of Stan G. Louie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stan G. Louie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stan G. Louie more than expected).
Fields of papers citing papers by Stan G. Louie
This network shows the impact of papers produced by Stan G. Louie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stan G. Louie. The network helps show where Stan G. Louie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stan G. Louie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 9 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 5 | |
| 8 | 2023 | 11 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 12 | |
| 11 | 2021 | 24 | |
| 12 | 2018 | 5 | |
| 13 | 2018 | 8 | |
| 14 | 2017 | 110 | |
| 15 | 2015 | 21 | |
| 16 | 2013 | 151 | |
| 17 | 2012 | 102 | |
| 18 | 2012 | 76 | |
| 19 | 2011 | 79 | |
| 20 | 2009 | 151 |
About Stan G. Louie
Stan G. Louie is a scholar working on Physiology, Oncology and Virology, having authored 151 papers that have together received 5.0k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (10 papers), Endoplasmic Reticulum Stress and Disease (10 papers), HIV/AIDS drug development and treatment (10 papers), Eicosanoids and Hypertension Pharmacology (9 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), PARP inhibition in cancer therapy (8 papers), Adenosine and Purinergic Signaling (8 papers) and Autophagy in Disease and Therapy (8 papers). The work is most often cited by research in Physiology (267 citations), Virology (260 citations) and Infectious Diseases (773 citations). Stan G. Louie has collaborated with scholars based in United States, Norway and Canada. Frequent co-authors include Axel H. Schönthal, Thomas C. Chen, Florence M. Hofman, Nicos A. Petasis, Encouse B. Golden, Hee‐Yeon Cho, Natalie Bzowej, Amy Rock Wohl, Maurizio Bonacini and Adel Kardosh.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.